A nurse takes the temperature of a participant in an Ebola vaccine trial in 2015 that was conducted jointly by the National Institutes of Health and the Liberian Ministry of Health.John Moore/Getty Images

Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach Megan on Signal at mmolteni.13.

The National Institutes of Health announced Thursday it will no longer allow subawards to foreign institutions, as part of a national security-minded overhaul to how the agency manages its $47 billion research funding portfolio. The change is likely to cause immediate disruptions to research projects around the world.

“Subawards” are NIH funds that a grant recipient can give another organization to carry out a specific piece of the project. It’s an increasingly common practice for scientists to issue subawards to collaborators in other countries, especially as biomedical research has become both more interdisciplinary and more global.

Advertisement

According to the new guidance, the NIH intends to create a new grant structure that will eliminate subawards, replacing them with linked awards that the agency says will allow it to track funds with more transparency. NIH plans to implement the new system no later than September 30. 

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe